Tocil
8 Topics FoundTocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and pros...
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and pros...
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and pros...
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and pros...
Actemra 180 mg/ml Subcutaneous Injection, Solution by Genentech, Inc. ## Package Codes: 50242-138-01, 50242-138-86 ## Active Ingredients: Tocilizumab
Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate by Genentech, Inc. ## Package Codes: 50242-135-01, 50242-135-04 ## Active Ingredients: Tocilizumab
Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate by Genentech, Inc. ## Package Codes: 50242-136-01, 50242-136-04 ## Active Ingredients: Tocilizumab
Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate by Genentech, Inc. ## Package Codes: 50242-137-01, 50242-137-04 ## Active Ingredients: Tocilizumab